Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008–2009)

A total of 3160 clinical isolates of Escherichia coli from intra-abdominal infections were collected during 2008–2009 from 13 European countries. The frequency of extended-spectrum β-lactamase (ESBL)-producing isolates in Europe was 11%. The most active antibiotics tested were typically imipenem, er...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical microbiology and infection 2012-03, Vol.18 (3), p.253-259
Hauptverfasser:	Hawser, S.P., Bouchillon, S.K., Lascols, C., Hackel, M., Hoban, D.J., Badal, R.E., Canton, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Amikacin Amikacin - pharmacology Anti-Bacterial Agents - pharmacology Antibacterial agents Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents beta -Lactamase beta-Lactamases - genetics beta-Lactamases - secretion beta-Lactams - pharmacology Biological and medical sciences Breakpoints carbapenemase Clinical isolates Drug Resistance, Bacterial Ertapenem Escherichia coli Escherichia coli - drug effects Escherichia coli - enzymology Escherichia coli - genetics Escherichia coli - isolation & purification Escherichia coli Infections - microbiology Europe Female Humans Imipenem Imipenem - pharmacology Infectious diseases Intra-abdominal infection Intraabdominal Infections - microbiology Male Medical sciences Microbial Sensitivity Tests Minimum inhibitory concentration Pharmacology. Drug treatments resistance SMART surveillance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!